Search company, investor...

Sequel Pharmaceuticals

sequelpharma.com

Sequel Pharmaceuticals has not claimed their Profile.

1 of Sequel Pharmaceuticals's competitors have claimed theirs

Here’s why one competitor wins customers.

Arena Pharmaceuticals logo

Merck is very pleased with the progress in our joint program with Arena,which is an example of our continuing commitment to partner with the best ofbiotech companies,

Compete with Sequel Pharmaceuticals?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Compete with Sequel Pharmaceuticals?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Compare Sequel Pharmaceuticals to Competitors

I
IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

A
Advent Pharmaceuticals

Advent Pharmaceuticals is a specialty pharmaceutical company focused on developing inhaled drug products using a dry powder inhalation delivery system. The products are mostly used for the treatment of asthma and other respiratory diseases.

V
Verva Pharmaceuticals

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

P
Piedmont Pharmaceuticals

Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.

K
Kytogenics Pharmaceuticals Limited

Kytogenics is a medical device company. It had developed the Nocc Hydrophilic Wound Dressing.Kytogenics Pharmaceuticals, Inc. is a biomedical company engaged in the development of products based on its medical device and drug delivery patented platform technology.

T
Terapio

Terapio is a biopharmaceutical company specializing in the development of a pipeline of therapies based on the transport protein, RLIP76.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.